Enliven Therapeutics shares owned by SRS Capital Advisors
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by SRS Capital Advisors
from 13F filings
Historical chart of SRS Capital Advisors investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by SRS Capital Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $2.1k | 137 | 15.41 |
| 2025-09-30 | $3.1k | 153 | 20.47 |
| 2024-12-31 | $2.3k | 103 | 22.50 |
| 2024-09-30 | $2.6k | 103 | 25.54 |
| 2024-06-30 | $2.4k | 103 | 23.38 |